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The migration of multilineage "passenger leukocytes" from 
transplanted organs and their ubiquitous survival in success-
fully treated human recipients for as long as 30 years (mi-
crochimerism) has been postulated to be an essential condi-
tion for organ allograft acceptance and the explanation for a 
number of previously enigmatic posttransplant events (1, 2). 
Following organ revascularization in either humans or ro-
dents, donor leukocytes appear in large numbers in the re-
cipient blood but usually diminish over a few days to a level 
undetectable with flow cytometry (2-5). We have construed 
the persistence of donor cells thereafter as prima facie evi-
dence of the presence of hematopoietic stem and precursor 
cells (1,2, 6). 
When the blood compartment is serially sampled in long-
surviving human organ recipients, the levels of donor cells 
fluctuate (7), presumably reflecting cyclic activity of these 
stem cells. Taniguchi et al. (8) showed that primitive CD45 + 
cells purified from adult mouse livers unfailingly reconsti-
tuted all hematolymphopoietic lineages in supralethally ir-
radiated adult mouse recipients. We present here direct ev-
idence that supralethally irradiated adult rats can be 
consistently rescued by syngeneic liver transplantation, and 
that heart transplantation has a less dramatic but signifi-
cant therapeutic effect. 
Inbred Lewis (RT1!, LEW) rats weighing 200-250 g (8-10 
weeks old) were purchased from Harlan Sprague Dawley 
(Indianapolis, IN) and kept in a laminar-flow specific-patho-
gen-free environment. Orthotopic liver and heterotopic (ab-
dominal) heart transplantation were performed as described 
previously (5). After death of the donor by exsanguination, 
the grafts were flushed intravascularly with chilled lactated 
Ringer's solution until the venous effiuent was clear. 
Bone marrow cells were harvested from the tibias and 
femurs, and processed in RPM I 1640 supplemented with 25 
mM Hepes buffer, 2 mM L-glutamine, 50 D/ml penicillin, and 
50 J..lg/ml streptomycin (all from Gibco, Grand Island, NY) (5). 
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Trypan blue exclusion testing uniformly showed >95% cell 
viability_ The cell suspensions were administered into the 
recipient penile vein. 
A reagent panel containing monoclonal antibodies against 
all of the principal leukocyte subsets was used to determine 
lineages of the control and reconstituted animals (panel 
available on request), Most experiments were performed 
with male donors and recipients. However, in 2 liver recipi-
ents, male ~ female transplantation was performed and the 
tissues and organs of the hematopoietically reconstituted 
recipient were studied with polymerase chain reaction and 
Southern hybridization, usiiig rat V-chromosome (sex deter-
mining region Y [SRY]) specific primers (9). This provided 
proof of hematopoietic sex change in the reconstituted ani-
mals as opposed to recovery of the cytoablated recipient stem 
cells. 
Recipients were irradiated with 9.5 Gy, delivered from a 
cesium source. All cell or organ transplantations were done 
4-8 hr after completion of irradiation. Survival was deter-
mined of animals receiving 4 different doses of syngeneic 
bone marrow, and of those given liver and heart grafts (Table 
1). In addition, 6 irradiated animals of similar size were 
given 3 ml of fresh whole blood, which was an estimated 251Jt 
of their total blood volume. This amount of transfusion ex-
ceeded by an estimated thousand-fold or more any residual 
blood in the thoroughly flushed organs used for transplanta-
tion. 
All untreated animals died within 12 days. Heart trans-
plantation significantly prolonged survival (P<0.05). One of 
6 cardiac recipients was permanently rescued and 4 of the 5 
others lived 2-6 days beyond the longest surviving non-
treated control. These results were at least as good as those 
obtained with a suboptimal dose of 0.5x 106 bone marrow 
cells (P=0.109 vs. control) and with the infusion of 3 ml of 
whole blood (P=0.007 vs. controll. Liver transplantation re-
sulted in permanent survival of 5 of 6 irradiated recipients 
with full multilineage reconstitution. a rescue effect that was 
not significantly different from that following infusion of 1,5, 
or lOX 106 bone marrow cells (Table 1). 
Because frequent blood sampling and other manipulations 
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TABLE 1. Survival of lethally irradiated (9,5 Gyl LEW rats after different types of syngeneic organ and cell transplantation 
Group Orgall/cells n Survival (daysl Survival rate Median (daysJ po 
1 
2 
3 
4 
5 
6 
7 
8 
None 6 10. 10. 10. 11, 12. 12 0/6 10.5 
Heart 6 11, 14. 14, 16. 18. > 100 116 15,0 <0.05 
Liver 6 16. >100X5 5/6 >100 <0,005 
Bone marrow 0,5 x 106 6 10. 11. 12. 15, 16. 17 0/6 13,5 NS 
Bone marrow 1 x 106 6 >100x6 6/6 >100 <0.005 
Bone marrow 5X106 6 >100X6 6/6 >100 <0.005 
Bone marrow 10 x 106 6 >100x6 6/6 >100 <0.005 
Whole blood 3 ml 6 12. 13. 13. 13, 13. 13 0/6 13.0 <0,01 
a Versus group 1 (Mann-Whitney U test). Group 2 vs, groups 4 and 8: NS; Group 3 vs, groups 5. 6, and 7: NS, 
jeopardized survival, hematologic studies were done in a 
separate cohort of irradiated animals, with subgroups that 
were untreated, infused with 1 X 106 or 1 X 107 unmodified 
bone marrow cells, or submitted to liver transplantation. The 
results, including weight gain, were compared with those in 
naive unaltered animals in the same environment (Figs, 
1-3). 
The rate and the extent of circulating leukocyte (Fig. 1) and 
hematocrit restoration (Fig. 2) were similar after liver trans-
plantation and infusions of 1 X 106 bone marrow cells, Rats 
given a lO-fold higher dose of bone marrow cells (lX107 ) 
recovered more quickly (Figs. 1 and 2), The sequence of 
lineage recovery was similar in the liver and bone marrow 
recipients, and appeared to be dependent on the number of 
progenitor cells, The FACS profile of animals after various 
kinds of hematopoietic reconstitution is shown in Figure 4. 
The reconstituted cells in cross-sex liver transplantations 
(male ---+ female) were predominantly donor (Fig. 5) and were, 
of course, least densely represented in the heart, 
The initial delay in postoperative weight gain of liver com-
pared with bone marrow recipients (Fig, 3) was explained by 
the greater stress and metabolic depletion associated with 
the hepatic replacement compared with the less traumatic 
penile vein infusion of bone marrow cells. After 3 weeks, the 
liver recipients had catch-up weight gain, and they achieved 
parity with all other reconstituted groups by day 50 (Fig. 3). 
These experiments suggest that the difference between the 
chimerism (and tolerance) following classical bone marrow 
transplantation and that produced by the donor ("passen-
ger") leukocytes of whole organs is purely semantic. While 
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FIGURE 1. Total white cell counts (mm3 J in normal and irradiated 
LEW rats (9.5 GyJ and rats given syngeneic transplants, after treat-
ment with red blood cell lysing buffer, Cells were counted in a 
hemacytometer .•. Normal Lewis (n=3); 0, radiation alone (n=3); 
., 1X106 bone marrow (n=6); D. lOx 106 bone marrow (n=4); &, 
OLTX (n=3). 
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FIGURE 2. Hematocrit (tail vein blood. microcentrifuge method) in 
same samples as Figure L 
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FIGURE 3. Body weight changes in animals of Figures 1 and 2. 
., Normal LEW (n-==3); 0, radiation alone (n=3); ., 1X106 bone 
marrow (n=6); D, 10X106 bone marrow (n=4); &. OLTx (n=3). 
describing the multilineage character of the microchimerism 
in human and animal organ recipients (1, 2, 6, 10. 11), we 
have emphasized the invariable histopathologic prominence 
of dendritic cells because their presence was so much in 
conflict with the literature preceding 1992. The previous 
literature had associated these cells almost exclusively with 
rejection rather than graft acceptance. We have recently 
summarized elsewhere the impressive evidence acquired 
since then of a key tolerogenic role played by the dendritic 
cells, particularly when iIi their precursor stages (J2). How-
ever, preoccupation with a single leukocyte lineage could 
obscure an understanding of the complex cell interactions 
that we are seeking to understand and manipulate. We be-
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FIGURE 4. Lineage ofperipheralleuko-
cytes shown in Figure l. Granulocytes 
were determined on blood smear fol-
lowing a-naphthyl acetate esterase and 
hematoxylin staining. Other FACS 
analysis of percentage of subpopula-
tions (mean::': SD) was by direct immu-
nofluorescence with antibodies to sur-
face markers, including OX1 (CD45). 
R7.3 (uj3 TCRl, W3/25 (CD4). OXS 
(CDS), OX33 (B-cells), and NK3.2.3 
(NK cells). 
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FIGURE 5. Polymerase chain reaction and Southern hybridization of 
organs and tissues 50 days after lethal irradiation and syngeneic 
liver transplantation. PBL, peripheral blood lymphocytes; Ty. thy-
mus; SP, spleen; BM, bone marrow; CLN, cervical lymph nodes. Male 
and female (negative) controls are included. 
lieve it unlikely that transplantation tolerance can be fully 
explained, reliably induced, or efficiently sustained by any 
single lineage (5, 6, 13). 
In the experiments reported herein, heart transplantation 
also had a significant effect on postirradiation survival, less 
dramatic than the liver but similar to that of a suboptimal 
dose of donor bone marrow or a large blood transfusion. The 
pennanent hematopoietic reconstitution of one of the heart 
recipients and prolongation of survival of 4 of 5 others 
strengthen our earlier contention that tolerogenicity is an 
inherent capability common to all organized tissues and or-
gans, with variations in outcome dictated by the quantity and 
lineage profile of bone marrow-derived leukocytes contained 
in the graft (), 2, 5, 6, 13). 
No record could be found in the literature suggesting that 
these simple and direct reconstitution experiments had been 
performed previously, presumably because of the assumption 
that organ transplantation involves a unidirectional host-
versus-graft immune reaction (the one-way paradigm). 
Leszczynski et a1. (}4) showed that lXl06 recipient inflam-
matory cells extracted from rejecting rat kidney allografts 
contained enough host stem cells to fully reconstitute su-
pralethally irradiated animals of the recipient strain. The 
experiments reported herein showed that the transplanted 
organ (especially the liver) brings enough donor stem cells to 
provide the basis of the sustained bidirectional immune re-
action that we have postulated to be the basis of allograft 
acceptance and the usual form of transplantation tolerance 
(the two-way paradigm [5, 15]). 
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ADDENDUM 
Two historical contributions in addition to Reference 8 were 
brought to our attention after submission of this article, 
adding evidence that stem cells are present in the adult 
mouse liver. The first, by Hays, Hays, and Golde (1978), 
described multiline age reconstitution following supralethal 
irradiation with cultured syngeneic hepatic NPCs obtained 
from adult mouse livers, especially if the liver was regener-
ating (following partial hepatectomy). The second publica-
tion, by Decker, Lohmann-Matthes, and Baccarrine (1988), 
also emphasized that cultured syngeneic liver NPCs could 
substitute for bone marrow cells for rescue after irradiation. 
Hays EF, Hays DM, Golde DW. Hemopoietic stern cells in mouse 
liver. Exp Hematol 1975; 6: IS. 
Decker T, Lohmann-Matthes ML. Baccarrini M. Liver-associated 
macrophage precursor cells proliferate under impairment of regu-
lar hemopoiesis. Eur J Immunol 19S5; IS: 697. 
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CD40-gp39 INTERACTIONS PLAY A CRITICAL ROLE DURING 
ALLOGRAFT REJECTION 
SUPPRESSION OF ALLOGRAFI' REJECTION BY BLOCKADE OF THE CD40-GP39 PATHWAy l 
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SHANNON C. RITCHIE,2 ALEJANDRO ARUFFO,4 ROSE HENDRIX,2 AND THOMAS C. PEARSON2.3 
Department of Surgery, Emory University School of Medicine, Atlanta. Georgia 30322, and Bristol-Myers Squibb 
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Studies in vivo have documented the importance of 
CD40-gp39 interactions in the development of T-de-
pendent antibody responses to foreign and auto-anti-
gens. In this report, we demonstrate that allograft re-
jection is also associated with strong induction of 
CD40 and gp39 transcripts. When treatment was initi-
ated at the time of transplant, MRl, a mAb specific for 
gp39, induced markedly prolonged survival of fully 
disparate murine cardiac allografts in both naive and 
sensitized hosts. However, when therapy was delayed 
until postoperative day 5, anti-gp39 failed to prolong 
1 This study was supported by NIH grants 1R29 Al33588-01Al, 
AR4268 7 , and 1F32 HL09226 - 0 1A1, an American Heart Association 
grant-in-aid, and an Emory University research committee grant. 
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3 Address correspondence to: Dr. Christian P. Larsen or Dr. Tho-
mas C. Pearson, Box M-ll Surgery Research, Emory University 
Hospital. 1364 Clifton Road, N.E., Atlanta. GA 30322 
4 Bristol-Myers Squibb Pharmaceutical Research Institute. 
graft survival. Allografts from recipients treated with 
MRl from the time of transplantation showed de-
creased expression of transcripts for the macrophage 
effector molecule, inducible nitric oxide synthase, but 
essentially unaltered expression of B7 molecules and T 
cell cytokine transcripts (interleukin [ILJ-2, interfer-
on-y, IL-IO, and IL-4) relative to control allografts. In 
addition, alloantibody responses in the MRl-treated 
mice were profoundly inhibited. However, our studies 
using B cell-deficient mice indicated that the ability of 
MRl to prolong allograft survival was not dependent on 
B cells. These data suggest that blockade of CD40-gp39 
interactions may inhibit allograft rejection primarily by 
interfering with T cell help for effector functions, rather 
than by interference with T cell activation. 
Activated T cells play a pivotal role in the rejection of 
allografts (1,2), Activation ofT cells to proliferate and secrete 
cytokines requires both recognition of major histocompatibil-
